Literature DB >> 7900159

Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.

L A Stanley1.   

Abstract

The observation that oncogenes are frequently activated in human tumours raises the question of whether these genes are involved in chemical carcinogenesis. H-ras activation is probably an initiating event in mouse skin and rat mammary gland systems. The H-ras oncogene is also important in mouse liver tumours; in mouse lung the K-ras gene is commonly activated. In both, the mutations observed are usually those predicted from the adduct-forming properties of the carcinogen. Among non-ras oncogenes, only raf and neu have been detected in experimental tumours. Tumour suppressor genes are frequently inactivated in human tumours. Searches for such phenomena in animal tumours have generally had disappointing results. p53 and Rb gene alterations are rarely observed in chemically-induced tumours. The reason may be that unknown tumour suppressor genes are involved in animal tumour development. Several novel genes have been identified using animal tumour susceptibility models. Thus, ras genes are important in chemical carcinogenesis, but as the methodology for studying other genes improves, their roles will be seen in perspective.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7900159     DOI: 10.1016/0300-483x(94)02991-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  13 in total

1.  Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone.

Authors:  C Wang; J Youssef; B Saran; P G Rothberg; M L Cunningham; A Molteni; M Badr
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Linkage mapping of the rat Tp53 gene on chromosome 10.

Authors:  F Canzian; T Ushijima; M Toyota; T Sugimura; M Nagao
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

Review 3.  Activated ras. Yet another player in melanoma?

Authors:  M Herlyn; K Satyamoorthy
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Involvement of oxidatively damaged DNA and repair in cancer development and aging.

Authors:  Barbara Tudek; Alicja Winczura; Justyna Janik; Agnieszka Siomek; Marek Foksinski; Ryszard Oliński
Journal:  Am J Transl Res       Date:  2010-05-15       Impact factor: 4.060

5.  DNA-protein crosslinks and p53 protein expression in relation to occupational exposure to formaldehyde.

Authors:  J Shaham; Y Bomstein; R Gurvich; M Rashkovsky; Z Kaufman
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

6.  Carcinogenic ability of Schistosoma haematobium possibly through oncogenic mutation of KRAS gene.

Authors:  Mónica C Botelho; Isabel Veiga; Paula A Oliveira; Carlos Lopes; Manuel Teixeira; José M Correia da Costa; José C Machado
Journal:  Adv Cancer Res Treat       Date:  2013-04-28

7.  Pulmonary Inflammation and KRAS Mutation in Lung Cancer.

Authors:  Phouthone Keohavong; Y Peter Di
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.

Authors:  J C Semenza; L H Weasel
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

9.  Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients.

Authors:  P Keohavong; H H Mady; W M Gao; J M Siegfried; J D Luketich; M F Melhem
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

Review 10.  Physical activity and cancer prevention : pathways and targets for intervention.

Authors:  Connie J Rogers; Lisa H Colbert; John W Greiner; Susan N Perkins; Stephen D Hursting
Journal:  Sports Med       Date:  2008       Impact factor: 11.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.